抗胆固醇与抗胰岛素治疗用于模拟器疾病预防
Oded Ben-Ari1,2,3,4, Shani Sarfati2, Barak Gordon1,2,3
1Department of Military Medicine, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
辛纳瑞有效地预防直升机模拟器疾病,与斯科波胺和安慰剂相比,显著减少症状. 这项研究建议在飞行员培训中使用cinnarizine进行模拟器疾病预防.
科学领域:
- 航空心理学 航空心理学
- 航空航天医学 航空航天医学
- 临床药理学 临床药理学
背景情况:
- 模拟器疾病是飞行员培训中的一个常见问题.
- 很少有研究研究了模拟器疾病的预防治疗方法.
- 运动疾病预防方法的研究很好,但模拟器特定干预措施的探索较少.
研究的目的:
- 为了比较辛纳瑞和斯科波胺在预防直升机模拟器疾病方面的疗效.
- 通过验证的模拟器疾病问卷 (SSQ) 来评估这些药物的有效性.
主要方法:
- 这是一项双盲随机试验,涉及41名直升机飞行员.
- 参与者在训练之前接受了斯科波胺,辛纳或安慰剂.
- 模拟器疾病的严重程度是通过初步和分发后的SSQ得分来评估的.
主要成果:
- 辛纳瑞显著改善了SSQ得分,将症状从73.30降低到30.92.
- 斯科波胺的效果低于辛纳和安慰剂.
- 这是第一个直接比较斯科波胺和辛纳利用于模拟器疾病预防的研究.
结论:
- 对于预防模拟器疾病,建议使用辛纳瑞 (cinnarizine) 与斯科波拉 (scopolamine) 相比.
- 这些发现表明,肉素可以作为接受模拟器训练的飞行员的可行预防剂.
更多相关视频
06:18Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation
Published on: February 7, 2020
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Equilibrium and Balance
Direct-Acting Cholinergic Agonists: Therapeutic Uses
